Shehnaaz Suliman

Insider profile

Currently holds positions in Ultragenyx Pharmaceutical Inc and Alector Inc

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Ultragenyx Pharmaceutical Inc Jan. 30, 2019 -
President, Chief Operating Officer Alector Inc Dec. 11, 2019 -
Senior Vice President - Corporate Development and Strategy Theravance Biopharma Inc July 31, 2017 - Dec. 31, 2019

Shehnaaz Suliman's trades of Terex Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-18 2026-06-16 PlS Planned sale
10,932 +16.6%
193.39
US$2,272,682
10,932 +16.6% 193.39 US$2,272,682
2026-06-18 2026-06-16 PlS Planned sale
40,059 -37.6%
46.93
US$1,841,939
40,059 -37.6% 46.93 US$1,841,939
2026-06-16 2026-06-16 PrS Proposed sale
57,632
343.77
US$4,638,912
57,632 343.77 US$4,638,912
2026-05-18 2026-05-18 S Sale
5,740 -17.0%
25.12
US$144,189
5,740 -17.0% 25.12 US$144,189
2026-05-18 2026-05-18 PrS Proposed sale
5,740
25.12
US$144,189
5,740 25.12 US$144,189
2021-12-14 2021-12-13 PlS Planned sale
10,898 -9.6%
21.73
US$236,802
10,898 -9.6% 21.73 US$236,802
2021-12-14 2021-12-13 PlS Planned sale
64,102 -36.1%
21.16
US$1,356,347
64,102 -36.1% 21.16 US$1,356,347
2021-12-14 2021-12-10 PlS Planned sale
8,874 -8.0%
22.33
US$198,192
8,874 -8.0% 22.33 US$198,192
2021-12-14 2021-12-10 PlS Planned sale
66,126 -37.2%
21.69
US$1,433,975
66,126 -37.2% 21.69 US$1,433,975
2021-12-10 2021-12-09 PlS Planned sale
2,643 -2.5%
23.40
US$61,858
2,643 -2.5% 23.40 US$61,858
2021-12-10 2021-12-09 PlS Planned sale
72,357 -40.7%
22.80
US$1,649,986
72,357 -40.7% 22.80 US$1,649,986
2021-12-10 2021-12-08 PlS Planned sale
38,489 -27.3%
23.01
US$885,690
38,489 -27.3% 23.01 US$885,690
2021-12-10 2021-12-08 PlS Planned sale
36,511 -20.6%
22.56
US$823,626
36,511 -20.6% 22.56 US$823,626